GLOBAL BRAIN SBSCESS DISEASE DIAGNOSTICS MARKET (2024 - 2030)

The global brain abscess disease diagnostics market was valued at USD 500 million in 2023 and is projected to reach a market size of USD 751.82 million by the end of 2030 growing at a CAGR of 6% over the forecast period, 2024-2030.

A buildup of pus within the brain is called a brain abscess. In the past, diagnosis was mainly done through CT scans and MRIs to detect abscesses. These methods had limited sensitivity and sometimes produced inaccurate results. Currently, this market has witnessed a good expansion owing to various technological advancements and other biomarkers. In the future, with extensive R&D activities, this market is set to see good growth. 

Key Market Insights:

Compared to conventional imaging techniques, advances in imaging technology resulted in a 20–30% increase in correct diagnoses.

Healthcare institutions were predicted to embrace AI-powered diagnostics by a 25–35% margin for the identification and characterization of brain abscesses.

The demand for sophisticated MRI and CT scan machines increased by 20–30% in the healthcare sector, especially for producers of diagnostic imaging equipment.

Research and development (R&D) expenditures by pharmaceutical firms treating brain abscesses with antibiotics increased by 25–35% to create more potent treatments.

In underdeveloped nations, brain abscesses account for around 8% of intracranial masses, but in developed nations, they account for 1% to 2%. To reduce the figures, measures are being taken to provide technologies and improve living conditions in underdeveloped and developing countries.

Brain Abscess Disease Diagnostics Market Drivers:

Technological advancements have been contributing to market success.

Over the years, technologies like MRI, PET scans, diffusion-weighted imaging, and other spectroscopy techniques have seen many improvements resulting in high resolution, efficiency, and accuracy. Additionally, peripherally enhanced lesion images have seen various improvements. Artificial intelligence and machine learning have been vital for various implementations of algorithms to aid precise detection, characterization, and pathologic outlines. Breakthroughs in surgery, neuroimaging diagnostic methods, and antibiotic usage have improved the prognosis for brain abscesses. Furthermore, R&D activities are being carried out to broaden human understanding.

The demand for early diagnosis has been fueling market growth.

An abscess in the brain is considered a medical emergency. The brain's blood and oxygen flow may be disrupted by swelling brought on by the abscess. Additionally, there's a chance that the abscess may rupture or explode. A brain abscess has the potential to be deadly and cause irreversible brain damage if left untreated. With changing lifestyles, there has been an increase in the prevalence of various illnesses. Environmental factors, food, and stress are a few reasons for the growing unhealthy population. Annually, 2500–3000 cases are detected in developed countries. Even though this is rare, people have been educating themselves about various diseases to prevent damage. Monthly and quarterly checkups have gained prominence. Besides, social media and governmental schemes have encouraged people to have easy access to medical facilities. This increased awareness has been helping the market for efficient diagnostic tools.

Brain Abscess Disease Diagnostics Market Restraints and Challenges:

Disparities in facilities, expenses, integration complexity, and limited knowledge are the main issues that are being experienced by the market.

Remote areas and other underdeveloped regions might not have equal access to healthcare facilities. Additionally, the presence of skilled medical professionals can be a hindrance. Secondly, the costs associated with the installation of these machines can be very high. Besides, maintenance and other upgrade charges add up. This becomes a hurdle for smaller clinics. Thirdly, integration challenges are faced while integrating diagnostic and other molecular tools with new technologies like AI and ML. This creates difficulties and can affect the working process. Furthermore, limited knowledge among the public regarding the disease can lead to severe repercussions. 

Brain Abscess Disease Diagnostics Market Opportunities:

Personalized medicine has been providing the market with an ample number of opportunities. Medications are designed based on the genetic makeup of an individual. Biomarkers are used for this, which give information about all the activities that take place in a cell. Diagnostic biomarkers are used to assess if a patient has a specific medical condition for which therapy may be recommended. Apart from this, advancements in point-of-care testing have been helping the market. Point-of-care testing that yields rapid and precise findings, particularly in distant or resource-constrained environments.

GLOBAL BRAIN ABSCESS DISEASE DIAGNOSTICS  MARKET REPORT COVERAGE:

Brain Abscess Disease Diagnostics Market Segmentation:

Market Segmentation: By Pathogen Type:

• Bacterial
• Fungal
• Parasite

Based on pathogen type, both the largest and fastest-growing segment in the market is bacterial infection. Bacteroides, Fusobacterium species, Streptococcus, Escherichia coli, Staphylococcus, Prevotella, and other gram-negative bacteria are the most prevalent ones. Bacterial infections are very easy to originate. They often originate from other body parts having an infection. This can include any dental, skin, or other infections. They spread rapidly raising the severity. Besides, they easily multiply since many of them are resistant to certain antibodies and drugs.

Market Segmentation: By Imaging Type:

• MRI (Magnetic Resonance Imaging)
• CT (Computed Tomography) Scan
• PET (Positron Emission Tomography) Scan

Based on imaging type, MRI (Magnetic Resonance Imaging) is both the largest and fastest-growing in the market. Sequences, like diffusion-weighted imaging, are commonly used. Acute abscesses may be detected with great sensitivity using magnetic resonance imaging (MRI). Additionally, it has good specificity for acute, chronic, or subacute abscesses. Furthermore, the MRI technique uses no ionizing radiation. This is a huge benefit for pregnant women and children. To distinguish between an infarction and the direct spread of the infection to the brain parenchyma, DWI is crucial. Advancements in this technique due to extensive research activities and partnerships are anticipated to further expand this category.

Market Segmentation: By End User:

• Hospitals and Clinics
• Diagnostic Imaging Centers
• Others

Based on end users, the hospitals and clinics segment is considered to be the largest one. This is because of factors like infrastructure, investments, collaborations, the presence of skilled expertise, assistance, accuracy, and people's trust. Diagnostic imaging centers are the fastest-growing. This is because of increasing funds, affordability, demand, global expansion, a greater workforce, and easy accessibility.

Market Segmentation: Regional Analysis:

• North America
• Asia-Pacific
• Europe
• South America
• Middle East and Africa

Based on region, North America is the largest region in this market, roughly holding a share of 28%. Reasons like the economy, investments, technological advancements, and healthcare facilities, presence of key players, industry partnerships, and medical staff accelerate the growth. Countries like the United States and Canada are at the forefront. Asia-Pacific is the fastest-growing because of the rising economy, funds, governmental initiatives, emerging companies, worldwide operations, urbanization, growing population, R&D activities, and licensed professionals. Countries like China, India, Japan, Australia, and Singapore are among the notable ones. This region holds a total share of 22%. Europe has also shown significant progress with countries like the United Kingdom and Germany at the top. Healthcare accessibility, facilities, and company investments are responsible for the upsurge.

COVID-19 Impact Analysis on the Global Brain Abscess Disease Diagnostics Market:

The outbreak of the virus hurt the market. This caused disruptions in the supply chain, affecting the import-export trade and resulting in an economic downfall. People were afraid to step out because of the fear of contamination. Hospital beds, oxygen cylinders, ventilators, and other healthcare applications faced a shortage due to the thousands of patients. Telehealth services are increasingly being adopted all over the world. As per Statista, a survey conducted among physicians in the United States revealed that 65 percent of participants had never utilized telemedicine before the COVID-19 epidemic. Around half of the patients seen by 43% of doctors at the height of the epidemic saw them using telehealth technology. People were able to contact doctors as well as other medical staff virtually for consultations, drug prescriptions, and other services. Most of the research activities were on hold due to the closing of research labs and institutions as per the guidelines and protocols. Besides, much funding was shifted toward the development of vaccines and other therapeutics for the coronavirus. Furthermore, the pandemic heightened awareness about having good physical and mental health. Post-pandemic, the market has started to pick up due to the upliftment of rules and regulations.

Latest Trends/ Developments:

The companies in this market are motivated to achieve a higher market share by implementing different strategies, such as acquisitions, partnerships, and investments. Companies are also spending heavily to improve existing creations while maintaining competitive pricing.

Molecular diagnostic techniques have been gaining significant prominence. The main methods are polymerase chain reaction (PCR) and next-generation sequencing (NGS). PCR is used to quickly create millions to billions of copies of a particular DNA sequence to study it in more detail. NGS is a technique for sequencing RNA and DNA. In a little amount of time, NGS can sequence tens of thousands of genes or whole genomes. Additionally, it may be used to find mutations and variations.

Key Players:

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems Corporation
• Thermo Fisher Scientific
• Roche Diagnostics
• Hitachi Healthcare
• Fujifilm Medical Systems
• Hologic, Inc.
• Agilent Technologies
• Carestream Health
• Esaote
• Shimadzu Corporation
• Mindray
• NeuroLogica Corporation

In August 2023, Voxelgrids Innovations Private Ltd. of Bangalore developed the first made-in-India MRI scanner, which was initially shown as a clinically proven instrument at the Sathya Sai Institute of Higher Medical Sciences in Bengaluru. To quickly cool the magnets, the MRI scanner employs liquid nitrogen, which is far more widely available and less expensive than liquid helium.

In September 2021, with a $5 million, investment, Zoho Corp. acquired a 25% share in Bengaluru-based Company Voxelgrids, which manufactures magnetic resonance imaging (MRI) scanners.  The investment, which will be delivered over the following two years in two tranches, is intended to support the nation's deep technological capabilities and intellectual property (IP) development.

In April 2022, a leading European supplier of diagnostic services, Unilabs, and GE Healthcare partnered to offer state-of-the-art digital technology and imaging equipment in Portugal. Thousands of Portuguese patients will benefit from improved access to treatment thanks to Unilabs' EUR 45 million investment, which is among the largest in the history of the nation's investments in healthcare diagnostics. The collaboration includes advanced imaging fleet services, mammography, X-ray machines, ultrasound and CT scanning technologies, and mammography equipment.

In August 2020, with an upfront cash payment of $275 million, Royal Philips announced that it has reached an agreement to buy Intact Vascular, Inc. Through the purchase, Intact Vascular's specialized Tack endovascular system will be combined with Philips' interventional imaging platform and diagnostic and therapeutic devices.